Health Care & Life Sciences » Biotechnology | TBG Diagnostics Ltd.

TBG Diagnostics Ltd. | Income Statement

Fiscal year is January-December. All values AUD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3,316.30
5,531.00
3,341.10
3,205.60
4,024.80
3,152.80
Cost of Goods Sold (COGS) incl. D&A
3,512.90
4,695.60
5,101.90
1,056.90
1,607.00
925.20
Gross Income
196.60
835.40
1,760.80
2,148.70
2,417.80
2,227.60
SG&A Expense
2,943.20
3,559.80
3,951.20
5,817.70
7,459.20
4,566.50
EBIT
3,139.80
2,724.50
5,712.10
3,669.00
5,041.40
2,338.90
Unusual Expense
-
-
-
311.20
-
390.60
Non Operating Income/Expense
130.60
81.40
72.10
463.90
-
113
Pretax Income
2,815.40
2,420.40
5,537.90
3,447.30
4,951.50
2,544.20
Income Tax
723.30
613.50
853.80
-
1,091.40
12.60
Consolidated Net Income
2,092.10
1,806.90
4,684.10
3,447.30
3,860.00
2,531.50
Net Income
2,092.10
1,806.90
4,684.10
3,447.30
3,852.70
2,531.50
Net Income After Extraordinaries
2,092.10
1,806.90
4,684.10
5,483.20
1,165.10
669.70
Net Income Available to Common
2,092.10
1,806.90
4,684.10
7,452.60
6,897.40
2,531.50
EPS (Basic)
0.07
0.03
0.08
0.07
0.03
0.02
Basic Shares Outstanding
27,895.80
55,285.30
55,285.30
185,476.40
217,587.30
217,587.30
EPS (Diluted)
0.07
0.03
0.08
0.07
0.03
0.02
Diluted Shares Outstanding
27,895.80
55,285.30
55,285.30
185,476.40
217,587.30
217,587.30
EBITDA
3,000.90
2,454.20
5,315.00
2,740.90
3,870.80
1,775.30
Non-Operating Interest Income
193.80
222.60
102.10
69.10
55.30
72.40
Minority Interest Expense
-
-
-
-
7.30
-

About TBG Diagnostics

View Profile
Address
101 Collins Street
Melbourne Victoria (VIC) 3000
Australia
Employees -
Website http://www.tbgbio.com
Updated 07/08/2019
TBG Diagnostics Ltd. engages in the research, development, and manufacture of biopharmaceuticals. It operates through the InVitro Diagnostics segment, which involves in the research of biological drugs and the retail and wholesale of veterinary drugs. The company was founded on September 26, 1989 and is headquartered in Melbourne, Australia.